Clinical Predictors of Port Infections in Adult Patients with Hematologic Malignancies

Review by: Rei Mitsuyama, Brown University, 2020 Introduction             Hematologic malignancies are a heterogeneous group of cancers for which cytotoxic chemotherapy is the mainstay of treatment. Patients often require ports (implantable venous access systems) to maintain reliable venous access for drug administration. Despite advances in antimicrobial therapy and dedication to Read more…

One-Year Analysis of the Prospective Multicenter SENTRY Clinical Trial: Safety and Effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava Filter

Monica Matsumoto, MS4, University of Chicago Pritzker School of Medicine Pulmonary embolism (PE) is the leading cause of death from venous thromboembolic (VTE) disease and is an important, preventable source of morbidity and mortality globally1. The incidence of PE has been rising with substantial treatment-associated costs, with the estimated cost Read more…

Outcomes of Transcatheter Arterial Embolization with a Modified N-Butyl Cyanoacrylate Glue for Spontaneous Iliopsoas and Rectus Sheath Hematomas in Anticoagulated Patients

Rei Mitsuyama, MS2, MD Student, Brown University Summary:             Spontaneous iliopsoas and rectus sheath hematomas arising in patients on anticoagulant therapy are more likely to require embolic treatment rather than conservative management. Of the numerous embolic agents available, Glubran 2 NBCA-MS glue seems to be an efficacious option that causes Read more…

Is Long-Term Anticoagulation Required after Stent Placement for Benign Superior Vena Cava Syndrome?

Author: Rei Mitsuyama, MS3, Brown University Introduction Benign superior vena cava (SVC) syndrome is caused by nonmalignant obstruction of the SVC. The most common causes are long-term central lines, long-term cardiac devices, and fibrosing mediastinitis. Symptoms may include headache, facial swelling, and upper limb edema which may present acutely or Read more…